person · Reporting owner

Lynton Nicholas Hollmeyer

Disclosed activity across 1 company

Tapewire entity: 32129
SEC CIK: 0001941467

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Cardlytics, Inc.

Report date July 01, 2026 · Filed July 06, 2026

Section 16 reporting ended · disclosed 2026-07-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	16,942	Reported balance After 2026-07-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-07-01 · Exercise / conversion · Acquired 157 · Balance 16,942 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
Common StockSEC Table I · non-derivative	Direct	18,442	Reported balance After 2026-07-01 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2026-07-01 · Exercise / conversion · Acquired 1,500 · Balance 18,442 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Common StockSEC Table I · non-derivative	Direct	18,754	Reported balance After 2026-07-01 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2026-07-01 · Exercise / conversion · Acquired 312 · Balance 18,754 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Common StockSEC Table I · non-derivative	Direct	21,504	Reported balance After 2026-07-01 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2026-07-01 · Exercise / conversion · Acquired 2,750 · Balance 21,504 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Common StockSEC Table I · non-derivative	Direct	19,353	Reported balance After 2026-07-02 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2026-07-02 · Sale · Disposed 2,151 · Balance 19,353 F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). F3: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-07-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2026-07-01 · Exercise / conversion · Disposed 157 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F5: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	4,500	Reported balance After 2026-07-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2026-07-01 · Exercise / conversion · Disposed 1,500 · Balance 4,500 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	938	Reported balance After 2026-07-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2026-07-01 · Exercise / conversion · Disposed 312 · Balance 938 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	19,250	Reported balance After 2026-07-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2026-07-01 · Exercise / conversion · Disposed 2,750 · Balance 19,250 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F7: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

F3: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose.

F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

F5: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.

F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

F7: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 02, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	2,151	$4.40	$9,453.65	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · nonDerivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,353 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). F3 · acquired: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	2,750	$0.00	$0.00	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · derivative · entry 9 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,250 Underlying: Common Stock · 2,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F7 · derivative.exercise_date: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F7 · derivative.expiration_date: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · balance_after: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	312	$0.00	$0.00	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · derivative · entry 8 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 938 Underlying: Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6 · derivative.exercise_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F6 · derivative.expiration_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · balance_after: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	1,500	$0.00	$0.00	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6 · derivative.exercise_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F6 · derivative.expiration_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · balance_after: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	157	$0.00	$0.00	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F5 · derivative.exercise_date: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	2,750	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	312	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	1,500	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
July 01, 2026 Filed Jul 6, 2026 21:39 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	157	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-047389 · wk-form4_1783373948.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	60,000	$0.00	$0.00	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · derivative · entry 11 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F7 · derivative.expiration_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · derivative · entry 10 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F7 · derivative.expiration_date: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	10,630	$0.00	$0.00	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · derivative · entry 9 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: The RSU award was originally for 85,035 shares. The RSU award vested in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026. F6 · derivative.expiration_date: The RSU award was originally for 85,035 shares. The RSU award vested in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	1,578	$0.00	$0.00	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · derivative · entry 8 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,578 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	582	$0.00	$0.00	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter. F4 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	40,296	$0.99	$39,893.04	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · nonDerivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,856 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2026. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $0.965 to $1.040, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	60,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · nonDerivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	12,500	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	10,630	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	1,578	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
April 01, 2026 Filed Apr 2, 2026 22:16 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	582	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-023348 · wk-form4_1775168217.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:12 UTC	Cardlytics, Inc. CDLX · Entity 7603	GrantRestricted Stock Unit · Derivative	220,000	$0.00	$0.00	Disclosure SEC source: 0001628280-26-010303 · wk-form4_1771625574.xml · derivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · derivative.expiration_date: The RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document
January 05, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	6,253	$1.17	$7,316.01	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,862 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2026. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	10,629	$0.00	$0.00	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,630 Underlying: Common Stock · 10,629 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F6 · derivative.expiration_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	1,578	$0.00	$0.00	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,156 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	581	$0.00	$0.00	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 582 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F4 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	10,629	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	1,578	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:56 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	581	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-000727 · wk-form4_1767657372.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
October 02, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	6,098	$2.27	$13,848.56	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,327 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	1,578	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,734 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F6 · derivative.expiration_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	581	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,163 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	10,630	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,259 Underlying: Common Stock · 10,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	1,578	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	581	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:07 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	10,630	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000141 · wk-form4_1759446419.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document
July 02, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	5,271	$1.78	$9,396.08	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,636 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.66 to $1.8451, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	1,578	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,312 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F6 · derivative.expiration_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	581	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,744 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	10,629	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,889 Underlying: Common Stock · 10,629 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	1,578	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	581	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	10,629	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000115 · wk-form4_1751495771.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
June 23, 2025 Filed Jun 25, 2025 20:11 UTC	Cardlytics, Inc. CDLX · Entity 7603	GrantPerformance Stock Unit · Derivative	9,375	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000109 · wk-form4_1750882299.xml · derivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 9,375 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F4 · derivative.expiration_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document
June 23, 2025 Filed Jun 25, 2025 20:11 UTC	Cardlytics, Inc. CDLX · Entity 7603	GrantRestricted Stock Units · Derivative	25,000	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000109 · wk-form4_1750882299.xml · derivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: 50% of the shares underlying the RSU award will vest on June 23, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through June 23, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. F2 · derivative.expiration_date: 50% of the shares underlying the RSU award will vest on June 23, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through June 23, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Read SEC document
April 22, 2025 Filed Apr 23, 2025 00:27 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	303	$1.51	$458.44	Disclosure SEC source: 0001666071-25-000058 · wk-form4_1745368027.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,119 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 20, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.485 to $1.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document
April 20, 2025 Filed Apr 23, 2025 00:27 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	682	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000058 · wk-form4_1745368027.xml · derivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: This RSU award was originally for 2,727 shares. 25% of the shares underlying the RSU award vested on each of April 20, 2022, April 20, 2023, April 20, 2024, and April 20, 2025. F4 · derivative.expiration_date: This RSU award was originally for 2,727 shares. 25% of the shares underlying the RSU award vested on each of April 20, 2022, April 20, 2023, April 20, 2024, and April 20, 2025. Read SEC document
April 20, 2025 Filed Apr 23, 2025 00:27 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionCommon Stock	682	Not disclosed	Not disclosed	Disclosure SEC source: 0001666071-25-000058 · wk-form4_1745368027.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document
April 02, 2025 Filed Apr 3, 2025 20:10 UTC	Cardlytics, Inc. CDLX · Entity 7603	SaleCommon Stock	5,754	$1.81	$10,391.72	Disclosure SEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,740 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:10 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Units · Derivative	1,578	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,890 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F6 · derivative.expiration_date: This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:10 UTC	Cardlytics, Inc. CDLX · Entity 7603	Exercise / conversionRestricted Stock Unit · Derivative	581	$0.00	$0.00	Disclosure SEC source: 0001666071-25-000050 · wk-form4_1743711006.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,325 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F5 · derivative.exercise_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F5 · derivative.expiration_date: The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.